Tobias Nordström
Papers
1
Total Citations
6
H-Index
1
About
Tobias Nordström is a leading urological researcher whose work centers on advancing minimally invasive treatments for localized prostate cancer, with a particular focus on focal therapy and irreversible electroporation (IRE). His major contribution is the landmark PRIS trial—a randomized controlled study comparing focal IRE therapy to radical treatment—which challenges the traditional paradigm of whole-gland intervention. This work demonstrates that IRE, a nonthermal technique using high-voltage electric pulses to selectively ablate cancerous lesions while preserving surrounding healthy tissue and anatomical structures, can achieve oncological control with significantly reduced side effects. Though recently published in 2023, the PRIS study has already garnered 6 citations, signaling its rapid impact on the field. Nordström’s research is pivotal in shifting prostate cancer management toward personalized, organ-sparing approaches, offering patients a middle ground between active surveillance and radical therapy. His findings are reshaping clinical guidelines and inspiring further investigation into focal ablation technologies, making him a key figure in the evolution of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1